Argus's products encompass numerous therapeutic areas, ranging from obesity management to metabolic diseases to anticancer treatments. These are areas where future demand will be high due to public health issues. To meet that demand, Argus has achieved the capability for large-scale production for one of its primary products, Orlistat, including its API, pellets, and capsules.